| Literature DB >> 33766404 |
Malini R Capoor1, Annapurna Parida2.
Abstract
COVID-19 pandemic and it's consequent biomedical waste is an unprecedented challenge worldwide. Biomedical waste generated during COVID-19 patient isolation, testing and care needs special consideration as it challenges the previous notion that only 15-20% of waste can be considered infectious. With establishment of new home quarantine facility, isolation/quarantine centres the chances of general waste getting contaminated with biomedical waste has increased exponentially. Through this systematic review the authors searched for all possible queries raised by different researchers on COVID19 waste management on Pubmed. A summary of all the different issues unique to COVID19 waste was prepared. Guidelines, rules and recommendation given by national and international agencies published till date were taken into account while trying to answer all the above questions raised by different studies. The key step in COVID19 waste management is segregation of biomedical waste from solid waste. Waste generated from COVID19 patients is like any other infectious waste, therefore creating public awareness about the COVID19 waste hazards and segregation at source is highlighted in all guidelines as a recommendation. These guidelines for management of waste generated during diagnostics and treatment of COVID-19 suspected or confirmed patients, are required to be followed in addition to existing practices under regulation. BMWM in COVID-19 context is a public health concern and is both a legal and social responsibility for all stakeholders.Entities:
Keywords: Biomedical waste management; CDC; COVID-19; CPCB Guidelines; WHO-WASH
Mesh:
Substances:
Year: 2021 PMID: 33766404 PMCID: PMC7985622 DOI: 10.1016/j.ijmmb.2021.03.003
Source DB: PubMed Journal: Indian J Med Microbiol ISSN: 0255-0857 Impact factor: 0.985
Colour Categories of BMW as per BMWM rules, 2016, amendments 2018,2019 and CPCB guidelines 2020.
∗Barcode label will have to be made available on every bag or container as per CPCB guidelines.
∗∗For disinfection of BMWM articles freshly prepared 1–2% Sodium hypochlorite is recommended.
∗∗∗1% Sodium hypochlorite is 1:100 dilution (525–615 ppm of available chlorine).
∗∗∗∗Hospital supply of sodium hypochlorite is 10% or 4% (please see label and manufacturers instructions).
∗∗∗∗∗All lab waste: patient's samples, blood bags, toxins, live and attenuated vaccines, cultures (liq/solid), devices used to transfer cultures need pretreatment by autoclaving/microwaving/hydroclaving etc-then their respective category plastic (red)/glass (blue).
Comparison of country or state or organization specific international guidelines with CPCB guidelines, 2020 as amended.
| Country/organisation | Covid-19 waste category and management | References |
|---|---|---|
| All COVID-19 waste should be collected in designated COVID-19 waste containers and preferably treated onsite. When on-site treatment, option is not available offsite transport can be done under strict supervision. Hand hygiene is must after handling COVID-19 waste [ | 17 | |
| OSHA guidelines state that COVID19 waste possess no extra threat and should be handled as any biomedical waste. SARS CoV-2 contaminated general municipality waste also should be treated as non-contaminated general waste. PPE, gloves, masks must be worn all time while handling COVID-19 waste. [43] | 28 | |
| Masks worn by COVID-19 confirmed orsuspected cases should be collected separately from the care takers and family members in paper bags. These bags can be handed over to the professional COVID-19 waste handling facilities through designated COVID-19 waste collectors. [44] | 29 | |
| Italian authorities divided waste into T1 and T2. Waste collected from homes with COVID-19 patients is classified as T1 and is considered infectious. Waste from all other homes without any COVID-19 patient, are under T2 category. T1 waste should be collected in double layered and requires no at source separation. No elderly person should be employed in handling of T1 waste. T2 waste can be collected and treated as per normal municipality waste. [ | 30 | |
| Waste generated during COVID-19 patient management is no different than waste generated by any other patient treatment. They are not considered category A waste should be treated as regulated medical waste (RMW). | ||
| As per CDC guidelines TCEQ had categorised COVID-19 waste as RMW. With all safety precaution COVID-19 waste should be treated as RMW and hand hygiene to be performed after handling. | 31 | |
| Medical Waste Management Program (MWMP) had categorised COVID-19 waste as RMW (as per CDC). No extra steps required for COVID-19 waste handling. | 32 | |
| A double-layered bag (2 bags) should be used for the collection of waste from COVID-19 isolation wards to ensure adequate strength and no leaks. Prior to handling over to Common Bio-medical Waste Treatment Facility (CBWTF), Collect and store biomedical waste separately. There should be a separate record of waste generated from COVID-19 isolation wards. The waste collection bags, bins, trolleys should be marked as ‘COVID-19 waste’. The labeling is to ensure the priority treatment and disposal immediately upon receipt at CBWTF. Only laboratory waste is to be pretreated on site, rest waste is treated at CBWTF level. | 4 |